Cargando…
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
BACKGROUND AND PURPOSE: Patients with locally advanced oropharynx squamous cell carcinoma have suboptimal outcomes with standard chemoradiation. Here, we evaluated toxicity and oncologic outcomes of dose escalation using radiosurgical boost for patients with unfavorable oropharynx squamous cell carc...
Autores principales: | Vempati, Prashant, Halthore, Aditya N., Teckie, Sewit, Rana, Zaker, Gogineni, Emile, Antone, Jeffrey, Zhang, Honglai, Marrero, Mihaela, Beadle, Kristin, Frank, Douglas K., Aziz, Mohamed, Paul, Doru, Ghaly, Maged |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731764/ https://www.ncbi.nlm.nih.gov/pubmed/33308265 http://dx.doi.org/10.1186/s13014-020-01718-w |
Ejemplares similares
-
Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer
por: Gogineni, Emile, et al.
Publicado: (2019) -
Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020) -
The Evolving Field of Stereotactic Body Radiation Therapy in Pancreatic Cancer
por: Ghaly, Maged, et al.
Publicado: (2019) -
Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
por: Nieder, Carsten, et al.
Publicado: (2014) -
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)